GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » 1-Year ROIIC %

Algernon Pharmaceuticals (XTER:BTI) 1-Year ROIIC % : -143.02% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Algernon Pharmaceuticals's 1-Year ROIIC % for the quarter that ended in Feb. 2024 was -143.02%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Algernon Pharmaceuticals's 1-Year ROIIC % or its related term are showing as below:

XTER:BTI's 1-Year ROIIC % is ranked worse than
75.31% of 1462 companies
in the Biotechnology industry
Industry Median: -4.78 vs XTER:BTI: -143.02

Algernon Pharmaceuticals 1-Year ROIIC % Historical Data

The historical data trend for Algernon Pharmaceuticals's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals 1-Year ROIIC % Chart

Algernon Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only -19.59 -650.63 100.16 -146.01 -53.29

Algernon Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -357.14 -1,010.84 -53.29 -184.95 -143.02

Competitive Comparison of Algernon Pharmaceuticals's 1-Year ROIIC %

For the Biotechnology subindustry, Algernon Pharmaceuticals's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Algernon Pharmaceuticals's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's 1-Year ROIIC % falls into.



Algernon Pharmaceuticals 1-Year ROIIC % Calculation

Algernon Pharmaceuticals's 1-Year ROIIC % for the quarter that ended in Feb. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -2.48 (Feb. 2024) - -4.492 (Feb. 2023) )/( 2.631 (Feb. 2024) - 3.859 (Feb. 2023) )
=2.012/-1.228
=-163.84%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Algernon Pharmaceuticals  (XTER:BTI) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Algernon Pharmaceuticals 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Algernon Pharmaceuticals (XTER:BTI) Business Description

Traded in Other Exchanges
Address
601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.